CAS 1620758-31-7

Empagliflozin Impurity 55

CAS: 1620758-31-7

Fórmula: C₂₃H₂₇ClO₇

Cor e Forma: White To Off-White Solid

Peso molecular: 450.91

Ref: 4Z-E-6369

Empagliflozin Impurity 50 (Mixture of Diastereomers)

CAS: 1620758-31-7, 1620758-32-8

Fórmula: C₂₃H₂₇ClO₇

Cor e Forma: White To Off-White Solid

Peso molecular: 450.91

Ref: 4Z-E-6365

Empagliflozin R-Furanose

CAS: 1620758-31-7

Fórmula: C₂₃H₂₇ClO₇

Peso molecular: 450.91

Ref: ST-EA-CP-E7007

Empagliflozin R/S-Furanose

CAS: 1620758-31-7, 1620758-32-8

Applications Empagliflozin R/S-Furanose is a mixture of R and S isomers of Empagliflozin Furanose. Both are byproducts in the synthesis of Empagliflozin drug (E521510), which is potent and selective inhibitor of sodium glucose co-transporter-2 (SGLT-2).
References Thomas, L., et al.: Diabetes. Obesity. Metabol. 14, 94 (2012); Grempler, R., et al.: Diabetes. Obesity. Metabol., 14, 83 (2012); Wang, X., et al.: Org. Lett., 16, 4090 (2014);

Fórmula: C₂₃H₂₇ClO₇

Cor e Forma: White To Off-White

Peso molecular: 450.909

Ref: TR-E521560

Empagliflozin R-furanose

CAS: 1620758-31-7

Empagliflozin R-furanose is a drug product that belongs to the class of drugs for treatment of type II diabetes. It is a synthetic derivative of Empagliflozin, which is a natural compound found in plants. Empagliflozin R-furanose has been shown to inhibit the activity of dipeptidyl peptidase 4 (DPP-4) and reduce postprandial glucose levels in healthy subjects. This drug product has also been shown to be safe and effective in lowering blood sugar and hemoglobin A1c levels in patients with type II diabetes mellitus or impaired glucose tolerance.

Fórmula: C₂₃H₂₇ClO₇

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 450.91 g/mol

Ref: 3D-IE181147

1,4-Anhydro-1,5-dihydroxy-empagliflozin-d4

Produto Controlado

CAS: 1620758-31-7, 1620758-32-8

Fórmula: C₂₃H₂₃D₄ClO₇

Cor e Forma: Neat

Peso molecular: 454.93

Ref: TR-A637897